AMIORG vs GKSL: Stock Comparison

AMIORG vs Gujarat Kidney & Super Speciality Ltd

Live data: 30 May 2025, 4:01 PM IST • Source: NSE and company filings

AMIORG is the larger company by market capitalisation. AMIORG shows a lower P/E, a higher ROE and a higher dividend yield, while Gujarat Kidney & Super Speciality Ltd shows a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of AMIORG and Gujarat Kidney & Super Speciality Ltd on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, AMIORG is more favourable on 4 of 13 scored metrics and GKSL on 7These counts are context-free and are not an overall rating.

Key Differences

Market Cap
AMIORG is the larger company
₹26,850 Cr vs ₹1,013 Cr
P/E Ratio
AMIORG has a lower P/E
43.06x vs 65.23x
P/B Ratio
GKSL has a lower P/B
4.01x vs 6.82x
EPS
GKSL has higher earnings per share
₹1.97 vs ₹0
Dividend Yield
AMIORG has a higher dividend yield
0.04% vs 0%
Qtr Sales Growth
GKSL has stronger quarterly sales growth
213% vs 0%
Qtr Profit Growth
GKSL has stronger quarterly profit growth
294% vs 0%
ROE
AMIORG has a higher ROE
12.15% vs 11.1%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Price

MetricAMIORGGKSL
Live Price₹1,176.3₹128.2
Day Change-0.31%0.71%
Volume2.43 L73,624
52-Week High₹1,194.2₹148.34
52-Week Low₹1,170.1₹98.36
Distance from 52W High-1.5%-13.58%

Valuation

MetricAMIORGGKSL
Market Cap₹26,850 Cr₹1,013 Cr
P/E Ratio43.06x65.23x
P/B Ratio6.82x4.01x
EPS₹0₹1.97
Book Value₹0₹32
Dividend Yield0.04%0%

Growth

MetricAMIORGGKSL
Revenue Growth (TTM YoY)0%0%
EPS Growth (TTM YoY)0%0%
Qtr Sales Growth0%213%
Qtr Profit Growth0%294%

Profitability & Leverage

MetricAMIORGGKSL
ROE12.15%11.1%
ROCE0%14.5%
Net Margin15.93%20.5%
Operating Margin22.09%32.8%
Debt to Equity0.01x0.12x

Shareholding

As of Sep 2025 • change vs previous quarter
MetricAMIORGGKSL
Promoter Holding0.33% 32.33 pp71.45%
FII Holding0.17% 16.77 pp4.88% 5.59 pp
DII Holding0.23% 22.15 pp0.56% 1.11 pp
Public Holding0.28% 27.73 pp23.1% 6.7 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AMIORG and Gujarat Kidney & Super Speciality Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.